Labiotech.eu

In Depth 29 Jan 2025

Pancreatic cancer: Oncolytics Biotech, Candel, and CytomX bring promising therapies to the clinic

Discover the treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to treat.

January 29, 2025 - 8 minutesmins - By Willow Shah-Neville

News and Trends 28 Jan 2025

ITM-11 succeeds in phase 3: The first big win for radiopharma?

Discover ITM and its cancer candidate ITM-11, as it brings one of the first big wins the radiopharmaceutical sector awaits.

January 28, 2025 - 9 minutesmins - By Jules Adam

Best in Biotech 27 Jan 2025

Top 19 most-performing biotech stocks of 2024

Discover the top-performing biotech stocks in 2024 – from oncology to psychedelics some companies showed remarkable results.

January 27, 2025 - 8 minutesmins - By Jules Adam

In Depth 24 Jan 2025

Why are there only 20 cell and gene therapies in Europe?

There are 20 cell and gene therapies on Europe’s market versus 43 in the U.S. Find out more about this ecosystem.

January 24, 2025 - 9 minutesmins - By Jules Adam

Podcast 24 Jan 2025

J.P. Morgan Annual Healthcare Conference 2025: trends and highlights you may have missed

With Orca Bio’s CEO, Ivan Dimov,, we take a look at some of the highlights from the 43rd Annual J.P. Morgan Healthcare Conference

January 24, 2025

In Depth 23 Jan 2025

mRNA, RNAi, circRNA, ASOs: A comparative guide to RNA therapeutics

In this review of RNA therapies, we paint an overview of what’s going on in a field that could address a number of diseases.

January 23, 2025 - 11 minutesmins - By Roohi Mariam Peter

Best in Biotech 22 Jan 2025

Curing ALS? Sixteen companies developing new treatments in 2025

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in 2025.

January 22, 2025 - 18 minutesmins - By Jules Adam

Best in Biotech 21 Jan 2025

14 biotech podcasts to tune into in 2025

Here is a list of 14 biotech podcasts to keep you up to date with the latest advances in the biotechnology industry.

January 21, 2025 - 8 minutesmins - By Roohi Mariam Peter

In Depth 20 Jan 2025

Is biotech M&A set to surge in 2025?

There is big hope for biotech M&A in 2025, with a resounding sense that activity will rise again as several important factors come into play.

January 20, 2025 - 6 minutesmins - By Willow Shah-Neville

In Depth 17 Jan 2025

Are PD-1 and PD-L1 checkpoint inhibitors as good as we thought?

Checkpoint inhibitors, especially those targeting PD-1 and PD-L1, are exploding in popularity. But how much of it is hype?

January 17, 2025 - 7 minutesmins - By Roohi Mariam Peter

Podcast 17 Jan 2025

Venture capital co-creation: The next big thing in biotech investment?

This week, we talked with Jessica Owen, co-founder of Initiate Ventures, a venture firm with an interesting dual model.

January 17, 2025

News and Trends 16 Jan 2025

Top biotech deals of December 2024

The month of December saw a variety of biotech deals take place to advance therapies across different stages in development.

January 16, 2025 - 9 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Pancreatic cancer: Oncolytics Biotech, Candel, and CytomX bring promising therapies to the clinic

ITM-11 succeeds in phase 3: The first big win for radiopharma?

Top 19 most-performing biotech stocks of 2024

Why are there only 20 cell and gene therapies in Europe?

J.P. Morgan Annual Healthcare Conference 2025: trends and highlights you may have missed

mRNA, RNAi, circRNA, ASOs: A comparative guide to RNA therapeutics

Curing ALS? Sixteen companies developing new treatments in 2025

14 biotech podcasts to tune into in 2025

Is biotech M&A set to surge in 2025?

Are PD-1 and PD-L1 checkpoint inhibitors as good as we thought?

Venture capital co-creation: The next big thing in biotech investment?

Top biotech deals of December 2024

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!